Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-28 @ 5:03 PM
Study NCT ID:
NCT00687804
Status:
COMPLETED
Last Update Posted:
2013-04-01
First Post:
2008-05-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-27
First Submit QC Date:
None
Study First Post Date:
2008-06-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-01-19
Results First Submit QC Date:
None
Results First Post Date:
2011-04-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-26
Last Update Post Date:
2013-04-01
Last Update Post Date Type:
ESTIMATED